Compass Therapeutics (CMPX) Interest Coverage Ratio (2018 - 2021)

Compass Therapeutics has disclosed Interest Coverage Ratio across 4 years of filings, most recently posting 333.36 for Q4 2021.

• Interest Coverage Ratio for Q4 2021 came in at 333.36, changed N/A year-over-year; the trailing twelve-month figure through Sep 2022 was 1070.97 (down 765.47% YoY), and the FY2021 annual result was 221.3, down 622.5% from the prior year.
• Interest Coverage Ratio came in at 333.36 for Q4 2021 at Compass Therapeutics, down from 75.05 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 7.09 in Q4 2019 to a low of 333.36 in Q4 2021.
• The 4-year median for Interest Coverage Ratio is 24.0 (2019), against an average of 53.36.
• Peak annual rise in Interest Coverage Ratio reached 33.06% in 2019, while the deepest fall reached 166.1% in 2019.
• Compass Therapeutics' Interest Coverage Ratio stood at 10.59 in 2018, then surged by 33.06% to 7.09 in 2019, then tumbled by 496.17% to 42.27 in 2020, then sank by 688.66% to 333.36 in 2021.
• The last three Interest Coverage Ratio figures came in at 333.36 (Q4 2021), 75.05 (Q3 2021), and 51.68 (Q1 2021), per Business Quant data.